Focus on Drug Approvals. This week the FDA approved Ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer. Ensartinib is a potent and specific ALK inhibitor.
Focus Biomolecules can supply Ensartinib for research applications. Contact us.
For Postdoc
Customers!
Website Created by Advanta Advertising LLC.
